To determine whether the ovarian cancer cells may serve as a potential source of the increased serum LRG1 levels in ovarian cancer patients, we quantified LRG1 mRNA expression in ovarian tumors compared to normal ovaries by gene microarray analysis (Figure 2A). Here, LRG1 is linked to ovarian carcinoma.